Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 124, Issue 1, 2006, Pages 101-105

  Chou, Yu Ching ^a,b   Chen, Yi Jen ^a,b   Lai, Chiung Ru ^a   Wang, Peng Hui ^a,b   Hsin Chan, ^a,b   Yuan, Chiou Chung ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cyclooxygenase 2 (COX 2); Endometriosis; Malignant transformation; Ovarian cancer

Indexed keywords

CYCLOOXYGENASE 2; CYTOKERATIN 20; CYTOKERATIN 7;

ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 29644435691     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.06.019     Document Type: Article

References (34)

1. R.B. Ness Endometriosis and ovarian cancer: thoughts on shared pathophysiology Am J Obstet Gynecol 189 2003 280 294
2. J.M. Heaps, R.K. Nieberg, and J.S. Berek Malignant neoplasms arising in endometriosis Obstet Gynecol 75 1990 1023 1028
3. I.F. Hitti, S.S. Glasberg, and S. Lubicz Clear cell carcinoma arising in extra ovarian endometriosis: report of three cases and review of the literature Gynecol Oncol 39 1990 314 320
4. R.C. Stern, R. Dash, R.C. Bentley, M.J. Snyder, A.F. Honey, and S.J. Robbey Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types Int J Gynecol Pathol 2001 133 139
5. M. Erzen, and J. Kovacic Relationship between endometriosis and ovarian cancer Eur J Gynaecol Oncol 6 1998 553 555
6. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
7. M. Tsujii, S. Kawano, and R.N. DuBois Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci USA 94 1997 3336 3340
8. X.H. Liu, A. Kirschenbaum, S. Yao, R. Lee, J.F. Holland, and A.C. Levine Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo J Urol 164 3 pt 1 2000 820 825
9. D.K. Gaffney, J. Holden, M. Davies, K. Zempolich, K.J. Murphy, and M. Dodson Elevated cyclooxygenase-2 expression correlate with diminished survival in carcinoma of the cervix treated with radiotherapy Int J Radiat Oncol Biol Phys 49 5 2001 1213 1217
10. H.S. Ryu, K.H. Chang, H.W. Yang, M.S. Kim, H.C. Kwan, and K.S. Oh High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion Gynecol Oncol 76 2000 320 325
11. H. Achiwa, Y. Yatabe, and T. Hida Prognostic significance of elevated cyclooxygenase-2 expression in primary resected lung adenocarcinoma Clin Cancer Res 5 1999 1001 1005
12. S. Tomozawa, N.H. Tsuno, and E. Sunamio Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis of colorectal cancer Br J Cancer 83 3 2000 324 328
13. C. Denkert, M. Kobel, and S. Pest Expression of Cyclooxygenase-2 is and independent prognostic factor in human ovarian carcinoma Am J Pathol 160 3 2002 893 903
14. E. Giovanucci, K.M. Egan, and D.J. Hunter Aspirin and the risk of colorectal cancer in women N Engl J Med 333 1995 609 614
15. E.M. Funkhouser, and G.B. Sharp Aspirin and reduced risk of esophageal cancer Cancer 76 1995 1116 1119
16. M.J. Thun, M.M. Namboodiri, and C.W. Health Jr. Aspirin use and reduced risk of fatal colon cancer N Engl J Med 324 1991 1593 1596
17. D.M. Schreinemachers, and R.B. Everson Aspirin use and lung, colon and breast cancer incidence in a prospective study Epidemiology 5 1994 138 146
18. M.M. Taketo Cyclooxygenase inhibitors in tumorigenesis (Part I) J Natl Cancer Inst 90 1998 1529 1536
19. M.M. Taketo Cyclooxygenase inhibitors in tumorigenesis (Part II) J Natl Cancer Inst 90 1998 1609 1615
20. R. Moll Cytokeratins in the histological diagnosis of malignant tumors Int J Biol Markers 9 2 1994 63 69
21. T. Stigbrand The versatility of cytokeratins as tumor markers Tumour Biol 22 1 2001 1 3
22. M. Nisolle, F. Casanas-Roux, and J. Donnez Coexpression of cytokeratin and vimentin in eutopic endometrium and endometriosis throughout the menstrual cycle: evaluation by a computerized method Fertility Sterility 64 1 1995 69 75
23. I.O. Song, S.R. Hong, and Y. Huh Expression of vimentin and cytokeratin in eutopic and ectopic endometrium of women with adenomyosis and ovarian endometrioma Am J Rep Immunol 40 1 1998 26 31
24. C.C. Wauters, F. Smedts, and L.G. Gerrits Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary Hum Pathol 26 1995 852 855
25. J. Rosai Ackerman's surgical pathology 8th ed. 1996 Mosby St. Louis
26. W. Remmele, and K.H. Schicketanz Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS) Pathol Res Pract 8 1993 227 245
27. M.L. Friedlander Prognostic factors in ovarian cancer Semin Oncol 25 1998 305 314
28. X. Jiang, A. Hitchcock, and E.J. Bryan Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci Cancer Res 56 1996 3534 3539
29. X. Jiang, S.J. Morland, A. Hitchcock, E.J. Thomas, and I.G. Campbell Alleotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage Cancer Res 58 1998 1707 1712
30. H. Ota, S. Igarashi, M. Sasaki, and T. Tanaka Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis Hum Reprod 16 2001 561 566
31. K. Shigemasa, X. Tian, L. Gu, Y. Shiroyama, N. Nagai, and Ohama K Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas Int J Oncol 22 1 2003 99 105
32. T. Okuda, J. Otsuka, and A. Sekizawa p53 Mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer Gynecol Oncol 88 3 2003 318 325
33. I. Skirnisdottir, T. Seidal, M.G. Karlsson, and B. Sorbe Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II Int J Oncol 26 1 2005 177 183
34. Y.J. Chen, L.S. Wang, and P.H. Wang High cyclooxygenase-2 expression in cervical adenocarcinoma Gynecol Oncol 88 2003 379 385